30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Verrica Pharmaceuticals Inc (VRCA)

Track

The most recent insider trading activity occurred on November 25, 2025, with significant buying activity reported by multiple executives, including the CEO and Interim CFO. This contrasts with earlier selling transactions in August 2024 and March 2025. The total value of the recent buy transactions is substantial.
Stock chart
Ticker: VRCA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Zawitz David
Chief Operating Officer
1 purchase — total 42,425 USD
Buy 25 Nov 2025
Value US$1,168,766.57 | Price 321.70 | Shares 573
Buy 25 Nov 2025
Value US$4,461,502.49 | Price 82.18 | Shares 36,883
Buy 25 Nov 2025
Value US$937,216.52 | Price 499.08 | Shares 74,113
Buy 25 Nov 2025
Value US$400,114.42 | Price 4.24 | Shares 94,311
Buy 25 Nov 2025
Value US$15,001.48 | Price 4.24 | Shares 3,536
Buy 25 Nov 2025
Value US$9,999.57 | Price 4.24 | Shares 2,357
Sale 17 Mar 2025
Value US$2,804.75 | Price 0.65 | Shares 4,315
Sale 27 Aug 2024
Value US$19,431.54 | Price 2.46 | Shares 7,899
Sale 27 Aug 2024
Value US$8,858.46 | Price 2.46 | Shares 3,601
Sale 27 Aug 2024
Value US$22,191.66 | Price 2.46 | Shares 9,021
Sale 27 Aug 2024
Value US$23,443.80 | Price 2.46 | Shares 9,530
Sale 27 Aug 2024
Value US$22,122.78 | Price 2.46 | Shares 8,993
Sale 26 Aug 2024
Value US$58,041.20 | Price 2.66 | Shares 21,820
Proposed sale 26 Aug 2024
Value US$79,500.00 | Price 2.65 | Shares 30,000
Sale 26 Aug 2024
Value US$26,302.08 | Price 2.66 | Shares 9,888
Proposed sale 26 Aug 2024
Value US$37,000.00 | Price 2.64 | Shares 14,000
Sale 26 Aug 2024
Value US$66,444.14 | Price 2.66 | Shares 24,979
Proposed sale 26 Aug 2024
Value US$90,100.00 | Price 2.65 | Shares 34,000
Sale 26 Aug 2024
Value US$69,646.78 | Price 2.66 | Shares 26,183
Proposed sale 26 Aug 2024
Value US$94,300.00 | Price 2.62 | Shares 36,000
Sale 26 Aug 2024
Value US$65,725.94 | Price 2.66 | Shares 24,709
Proposed sale 26 Aug 2024
Value US$90,100.00 | Price 2.65 | Shares 34,000
Sale 23 Jul 2024
Value US$600.28 | Price 6.98 | Shares 86
Sale 23 Jul 2024
Value US$802.70 | Price 6.98 | Shares 115
Sale 23 Jul 2024
Value US$635.18 | Price 6.98 | Shares 91
Sale 23 Jul 2024
Value US$1,074.92 | Price 6.98 | Shares 154
Sale 22 Jul 2024
Value US$130,052.26 | Price 7.06 | Shares 18,421
Proposed sale 22 Jul 2024
Value US$130,253.00 | Price 6.97 | Shares 18,695
Sale 22 Jul 2024
Value US$179,754.66 | Price 7.06 | Shares 25,461
Proposed sale 22 Jul 2024
Value US$180,048.00 | Price 6.97 | Shares 25,840
Sale 22 Jul 2024
Value US$152,841.94 | Price 7.06 | Shares 21,649
Proposed sale 22 Jul 2024
Value US$153,085.00 | Price 6.97 | Shares 21,971
Sale 22 Jul 2024
Value US$229,231.14 | Price 7.06 | Shares 32,469
Proposed sale 22 Jul 2024
Value US$229,628.00 | Price 6.97 | Shares 32,953
Buy 29 Dec 2023
Value US$838,203.76 | Price 7.24 | Shares 115,774
Buy 28 Dec 2023
Value US$892,901.28 | Price 7.08 | Shares 126,116
Buy 27 Dec 2023
Value US$574,027.20 | Price 7.20 | Shares 79,726
Buy 26 Dec 2023
Value US$354,691.48 | Price 6.49 | Shares 54,652
Buy 22 Dec 2023
Value US$1,667,500.00 | Price 6.67 | Shares 250,000
Buy 21 Dec 2023
Value US$1,234,000.00 | Price 6.17 | Shares 200,000
Buy 19 Dec 2023
Value US$1,484,762.88 | Price 5.36 | Shares 277,008
Buy 18 Dec 2023
Value US$2,471,953.43 | Price 5.41 | Shares 456,923
Buy 15 Dec 2023
Value US$2,985,000.00 | Price 5.97 | Shares 500,000
Sale 15 Nov 2023
Value US$33,460.02 | Price 2.97 | Shares 11,266
Sale 15 Nov 2023
Value US$34,327.26 | Price 2.97 | Shares 11,558
Sale 15 Nov 2023
Value US$28,607.04 | Price 2.97 | Shares 9,632
Sale 15 Nov 2023
Value US$9,016.92 | Price 2.97 | Shares 3,036
Sale 15 Nov 2023
Value US$34,327.26 | Price 2.97 | Shares 11,558
Proposed sale 14 Nov 2023
Value US$96,522.00 | Price 2.93 | Shares 32,943
Sale 14 Nov 2023
Value US$63,229.40 | Price 2.93 | Shares 21,580
Proposed sale 14 Nov 2023
Value US$96,522.00 | Price 2.93 | Shares 32,943
Sale 14 Nov 2023
Value US$64,873.13 | Price 2.93 | Shares 22,141
Proposed sale 14 Nov 2023
Value US$99,028.00 | Price 2.93 | Shares 33,798
Sale 14 Nov 2023
Value US$54,064.36 | Price 2.93 | Shares 18,452
Proposed sale 14 Nov 2023
Value US$82,529.00 | Price 2.93 | Shares 28,167
Sale 14 Nov 2023
Value US$17,043.81 | Price 2.93 | Shares 5,817
Proposed sale 14 Nov 2023
Value US$26,015.00 | Price 2.93 | Shares 8,879
Sale 14 Nov 2023
Value US$64,873.13 | Price 2.93 | Shares 22,141
Proposed sale 14 Nov 2023
Value US$99,028.00 | Price 2.93 | Shares 33,798
Proposed sale 24 Jul 2023
Value US$137,837.00 | Price 4.80 | Shares 28,699
Sale 24 Jul 2023
Value US$138,616.17 | Price 4.83 | Shares 28,699
Proposed sale 24 Jul 2023
Value US$243,398.00 | Price 4.80 | Shares 50,677
Sale 24 Jul 2023
Value US$244,769.91 | Price 4.83 | Shares 50,677
Proposed sale 24 Jul 2023
Value US$162,285.00 | Price 4.80 | Shares 33,789
Sale 24 Jul 2023
Value US$163,200.87 | Price 4.83 | Shares 33,789
Proposed sale 24 Jul 2023
Value US$183,769.00 | Price 4.80 | Shares 38,262
Sale 24 Jul 2023
Value US$184,805.46 | Price 4.83 | Shares 38,262
Buy 24 Jul 2023
Value US$1,004,000.00 | Price 5.02 | Shares 200,000
Buy 11 Jul 2022
Value US$25,500.00 | Price 3.40 | Shares 7,500
Buy 5 Jul 2022
Value US$9,999,998.40 | Price 2.10 | Shares 4,761,904
Buy 5 Jul 2022
Value US$49,998.90 | Price 2.10 | Shares 23,809
Buy 5 Jul 2022
Value US$499,999.50 | Price 2.10 | Shares 238,095
Buy 5 Jul 2022
Value US$11,999.40 | Price 2.10 | Shares 5,714
Buy 5 Jul 2022
Value US$2,999,999.10 | Price 2.10 | Shares 1,428,571
Buy 5 Jul 2022
Value US$49,998.90 | Price 2.10 | Shares 23,809
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-25 B Purchase
Zawitz David

Chief Operating Officer

Officer
573 +16.4%
321.70
US$1,168,767 		573 +16.4% 321.70 US$1,168,767
2025-11-25 2025-11-25 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
36,883 +31.1%
82.18
US$4,461,502 		36,883 +31.1% 82.18 US$4,461,502
2025-11-25 2025-11-25 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
74,113 -24.4%
499.08
US$937,217 		74,113 -24.4% 499.08 US$937,217
2025-11-25 2025-11-25 B Purchase
Rieger Jayson

CEO and President

Executive Director
94,311 +106.8%
4.24
US$400,114 		94,311 +106.8% 4.24 US$400,114
2025-11-25 2025-11-25 B Purchase
1.4
Kirby John J.

Interim CFO

Officer
3,536 +65.2%
4.24
US$15,001 		3,536 +65.2% 4.24 US$15,001
2025-11-25 2025-11-25 B Purchase
1.7
Rosenberg Noah L.

CMO

Officer
2,357 +inf%
4.24
US$10,000 		2,357 +inf% 4.24 US$10,000
2025-03-18 2025-03-17 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
4,315 -2.4%
0.65
US$2,805 		4,315 -2.4% 0.65 US$2,805
2024-08-28 2024-08-27 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
7,899 -15.0%
2.46
US$19,432 		7,899 -15.0% 2.46 US$19,432
2024-08-28 2024-08-27 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,601 -3.7%
2.46
US$8,858 		3,601 -3.7% 2.46 US$8,858
2024-08-28 2024-08-27 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
9,021 -4.0%
2.46
US$22,192 		9,021 -4.0% 2.46 US$22,192
2024-08-28 2024-08-27 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
9,530 -8.3%
2.46
US$23,444 		9,530 -8.3% 2.46 US$23,444
2024-08-28 2024-08-27 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
8,993 -11.0%
2.46
US$22,123 		8,993 -11.0% 2.46 US$22,123
2024-08-28 2024-08-26 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
21,820 -29.3%
2.66
US$58,041 		21,820 -29.3% 2.66 US$58,041
2024-08-28 2024-08-26 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
9,888 -9.2%
2.66
US$26,302 		9,888 -9.2% 2.66 US$26,302
2024-08-28 2024-08-26 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
24,979 -10.0%
2.66
US$66,444 		24,979 -10.0% 2.66 US$66,444
2024-08-28 2024-08-26 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
26,183 -18.5%
2.66
US$69,647 		26,183 -18.5% 2.66 US$69,647
2024-08-28 2024-08-26 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
24,709 -23.1%
2.66
US$65,726 		24,709 -23.1% 2.66 US$65,726
2024-08-26 2024-08-26 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
36,000
2.62
US$94,300 		36,000 2.62 US$94,300
2024-08-26 2024-08-26 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
14,000
2.64
US$37,000 		14,000 2.64 US$37,000
2024-08-26 2024-08-26 PrS Proposed sale
3.2
White Ted

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
30,000
2.65
US$79,500 		30,000 2.65 US$79,500
2024-07-23 2024-07-23 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
86 -0.1%
6.98
US$600 		86 -0.1% 6.98 US$600
2024-07-23 2024-07-23 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
115 -0.1%
6.98
US$803 		115 -0.1% 6.98 US$803
2024-07-23 2024-07-23 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
91 -0.1%
6.98
US$635 		91 -0.1% 6.98 US$635
2024-07-23 2024-07-23 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
154 -0.1%
6.98
US$1,075 		154 -0.1% 6.98 US$1,075
2024-07-23 2024-07-22 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
18,421 -14.6%
7.06
US$130,052 		18,421 -14.6% 7.06 US$130,052
2024-07-23 2024-07-22 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
25,461 -19.2%
7.06
US$179,755 		25,461 -19.2% 7.06 US$179,755
2024-07-23 2024-07-22 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
21,649 -13.3%
7.06
US$152,842 		21,649 -13.3% 7.06 US$152,842
2024-07-23 2024-07-22 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
32,469 -11.5%
7.06
US$229,231 		32,469 -11.5% 7.06 US$229,231
2024-07-22 2024-07-22 PrS Proposed sale
3.2
White Ted

Officer

Officer
32,953
6.97
US$229,628 		32,953 6.97 US$229,628
2024-07-22 2024-07-22 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
18,695
6.97
US$130,253 		18,695 6.97 US$130,253
2024-07-22 2024-07-22 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
21,971
6.97
US$153,085 		21,971 6.97 US$153,085
2024-07-22 2024-07-22 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
25,840
6.97
US$180,048 		25,840 6.97 US$180,048
2023-12-29 2023-12-29 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
115,774 +1.7%
7.24
US$838,204 		115,774 +1.7% 7.24 US$838,204
2023-12-29 2023-12-28 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
126,116 +1.8%
7.08
US$892,901 		126,116 +1.8% 7.08 US$892,901
2023-12-29 2023-12-27 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
79,726 +1.2%
7.20
US$574,027 		79,726 +1.2% 7.20 US$574,027
2023-12-26 2023-12-26 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
54,652 +0.8%
6.49
US$354,691 		54,652 +0.8% 6.49 US$354,691
2023-12-26 2023-12-22 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
250,000 +3.9%
6.67
US$1,667,500 		250,000 +3.9% 6.67 US$1,667,500
2023-12-26 2023-12-21 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
200,000 +3.2%
6.17
US$1,234,000 		200,000 +3.2% 6.17 US$1,234,000
2023-12-19 2023-12-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
277,008 +4.6%
5.36
US$1,484,763 		277,008 +4.6% 5.36 US$1,484,763
2023-12-19 2023-12-18 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
456,923 +8.2%
5.41
US$2,471,953 		456,923 +8.2% 5.41 US$2,471,953
2023-12-19 2023-12-15 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
500,000 +9.9%
5.97
US$2,985,000 		500,000 +9.9% 5.97 US$2,985,000
2023-11-16 2023-11-15 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
11,266 -10.9%
2.97
US$33,460 		11,266 -10.9% 2.97 US$33,460
2023-11-16 2023-11-15 S Sale
3.2
White Ted

President and CEO

Executive Director
11,558 -6.4%
2.97
US$34,327 		11,558 -6.4% 2.97 US$34,327
2023-11-16 2023-11-15 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
9,632 -21.9%
2.97
US$28,607 		9,632 -21.9% 2.97 US$28,607
2023-11-16 2023-11-15 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,036 -3.4%
2.97
US$9,017 		3,036 -3.4% 2.97 US$9,017
2023-11-16 2023-11-15 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
11,558 -8.6%
2.97
US$34,327 		11,558 -8.6% 2.97 US$34,327
2023-11-16 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-11-16 2023-11-14 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
21,580 -17.2%
2.93
US$63,229 		21,580 -17.2% 2.93 US$63,229
2023-11-16 2023-11-14 S Sale
3.2
White Ted

President and CEO

Executive Director
22,141 -10.9%
2.93
US$64,873 		22,141 -10.9% 2.93 US$64,873
2023-11-16 2023-11-14 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
18,452 -29.5%
2.93
US$54,064 		18,452 -29.5% 2.93 US$54,064
2023-11-16 2023-11-14 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
5,817 -6.1%
2.93
US$17,044 		5,817 -6.1% 2.93 US$17,044
2023-11-16 2023-11-14 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
22,141 -14.1%
2.93
US$64,873 		22,141 -14.1% 2.93 US$64,873
2023-11-15 2023-11-14 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
28,167
2.93
US$82,529 		28,167 2.93 US$82,529
2023-11-15 2023-11-14 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
8,879
2.93
US$26,015 		8,879 2.93 US$26,015
2023-11-15 2023-11-14 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-07-27 2023-07-24 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
28,699
4.80
US$137,837 		28,699 4.80 US$137,837
2023-07-27 2023-07-24 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
50,677
4.80
US$243,398 		50,677 4.80 US$243,398
2023-07-27 2023-07-24 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,789
4.80
US$162,285 		33,789 4.80 US$162,285
2023-07-27 2023-07-24 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
38,262
4.80
US$183,769 		38,262 4.80 US$183,769
2023-07-25 2023-07-24 S Sale
3.2
White Ted

President and CEO

Executive Director
50,677 -28.2%
4.83
US$244,770 		50,677 -28.2% 4.83 US$244,770
2023-07-25 2023-07-24 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
28,699 -29.0%
4.83
US$138,616 		28,699 -29.0% 4.83 US$138,616
2023-07-25 2023-07-24 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
38,262 -37.9%
4.83
US$184,805 		38,262 -37.9% 4.83 US$184,805
2023-07-25 2023-07-24 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
33,789 -29.2%
4.83
US$163,201 		33,789 -29.2% 4.83 US$163,201
2023-07-24 2023-07-24 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
200,000 +2.6%
5.02
US$1,004,000 		200,000 +2.6% 5.02 US$1,004,000
2022-07-11 2022-07-11 B Purchase
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
7,500 +91.3%
3.40
US$25,500 		7,500 +91.3% 3.40 US$25,500
2022-07-05 2022-07-05 B Purchase
4.0
Manning Paul B
Non-Executive Director Large shareholder
4,761,904 +53.6%
2.10
US$9,999,998 		4,761,904 +53.6% 2.10 US$9,999,998
2022-07-05 2022-07-05 B Purchase
3.5
Goldenberg Gary

Chief Medical Officer

Officer
23,809 +inf%
2.10
US$49,999 		23,809 +inf% 2.10 US$49,999
2022-07-05 2022-07-05 B Purchase
3.9
Stalfort John A III
Non-Executive Director
238,095 +51.5%
2.10
US$500,000 		238,095 +51.5% 2.10 US$500,000
2022-07-05 2022-07-05 B Purchase
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
5,714 +228.6%
2.10
US$11,999 		5,714 +228.6% 2.10 US$11,999
2022-07-05 2022-07-05 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,428,571 +39.6%
2.10
US$2,999,999 		1,428,571 +39.6% 2.10 US$2,999,999
2022-07-05 2022-07-05 B Purchase
3.2
White Ted

President and CEO

Executive Director
23,809 +420.9%
2.10
US$49,999 		23,809 +420.9% 2.10 US$49,999
Explore more

More insider trading research around Verrica Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America